Metropolis subsidiary MQSPL approves ₹1 lakh OCRPS issue to Dr. Puneet Nigam
- MQSPL approved issuance of 10,000 OCRPS at ₹10 face value each
- Total consideration for the share issue is ₹1,00,000
- Dr. Puneet Kumar Nigam, former CQO, is the proposed allottee
- Conversion to equity shares expected within six years via tranches
*this image is generated using AI for illustrative purposes only.
Metropolis Healthcare disclosed that its wholly owned subsidiary, Metropolis Quality Solutions Private Limited (MQSPL), has approved the issuance of Optionally Convertible Redeemable Preference Shares (OCRPS). The board authorized the offer on August 20, 2026, as part of a strategic capital structure adjustment for the newly incorporated entity.
The issuance involves 10,000 OCRPS with a face value of ₹10 each, issued at par. The total consideration amounts to ₹1,00,000. Dr. Puneet Kumar Nigam, the former Chief Quality Officer of the company, is the proposed allottee. The disclosure confirmed that Dr. Nigam does not belong to the promoter or promoter group of the listed entity.
Transaction Structure
The OCRPS will convert into equity shares at a ratio of 1:1. This conversion is subject to specific terms and conditions attached to the issuance and will be executed in tranches. The complete conversion process is expected to take up to six years.
Upon successful subscription and subsequent conversion, MQSPL will cease to be a wholly owned subsidiary but will remain a subsidiary of Metropolis Healthcare. The transaction falls outside the scope of a Scheme of Arrangement, and Regulation 37A of the SEBI Listing Regulations is not applicable.
Subsidiary Profile
MQSPL was incorporated on September 15, 2025, under the Indian Companies Act, 2013. As a newly formed entity, it has not yet commenced business operations. Consequently, it contributed no turnover, revenue, income, or net worth to the parent company during the last financial year.
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kamlesh Chandrashekhar Kulkarni, Head – Legal & Secretarial, signed the intimation sent to BSE Limited and National Stock Exchange of India Limited.
Historical Stock Returns for Metropolis Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.56% | -2.10% | -5.74% | +13.89% | +0.92% | -21.22% |
What strategic business opportunities is Metropolis Healthcare targeting for MQSPL that justify the equity infusion and the involvement of a former Chief Quality Officer?
How might the gradual conversion of OCRPS into equity shares over six years impact Metropolis Healthcare's consolidated financial statements and effective control metrics?
Does the issuance of preference shares to a non-promoter insider signal potential future spin-off plans or specialized service offerings distinct from the parent company's core diagnostics business?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
